Senti Biosciences, Inc. — Director's Dealing 2025

Mar 14, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Senti Biosciences, Inc. (SNTI)
CIK: 0001854270
Period of Report: 2025-03-10

Reporting Person: Celadon Partners SPV 24 (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-10	Common Stock	C	9777000	—	Acquired	9777000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-10	Series A Convertible Preferred Stock	$	C	9777	Disposed		Common Stock (9777000)	Direct

Footnotes

F1: Each share of Series A Convertible Preferred Stock (the "Series A Preferred Stock") was convertible into 1,000 shares of Common Stock either (i) automatically, at the Issuer's option or (ii) upon the election of the holder. On March 10, 2025, the Issuer exercised its right to automatically convert each share of Series A Preferred Stock, resulting in the acquisition of 9,777,000 shares of Common Stock. The Series A Preferred Stock had no expiration date.